The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

Published:2004-02-01 Issue:3 Volume:64 Page:830-835
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Foulkes William D.,Brunet Jean-Sébastien,Stefansson Ingunn M.,Straume Oddbjørn,Chappuis Pierre O.,Bégin Louis R.,Hamel Nancy,Goffin John R.,Wong Nora,Trudel Michel,Kapusta Linda,Porter Peggy,Akslen Lars A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer;iScience;2024-08

2. Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer;Scientific Reports;2023-10-20

3. FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress;Molecular Cell;2023-10

4. Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment;Journal of Experimental & Clinical Cancer Research;2023-08-18

5. Proteolysis Targeting Chimera (PROTAC) as a promising novel therapeutic modality for the treatment of triple‐negative breast cancer (TNBC);Drug Development Research;2023-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP